Form 4 for IBM IBM
Accepted 2024-02-23 00:00:00 ET · period of report 2024-02-21 · accession 0001562180-24-001701 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-23 | 2024-02-21 | IBM | BROWDY MICHELLE H | SVP | F - Tax | $180.87 | -2,118 | 121.5K | -2% | -$383.1K |
| DM | 2024-02-23 | 2024-02-21 | IBM | BROWDY MICHELLE H | SVP | M - OptEx | $0.00 | +4,146 | 121.4K | +4% | $0 |
| DM | 2024-02-23 | 2024-02-21 | IBM | BROWDY MICHELLE H | SVP | A - Grant | $0.00 | +42.4K | 7,073 | New | $0 |
| DM | 2024-02-23 | 2024-02-21 | IBM | BROWDY MICHELLE H | SVP | M - OptEx | $0.00 | -4,146 | 3,757 | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-21 | F | D | 959 | $180.87 | 120,416.42 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-21 | M | A | 2,269 | $0.00 | 122,685.42 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-21 | F | D | 1,159 | $180.87 | 121,526.42 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-21 | M | A | 1,877 | $0.00 | 121,375.42 | D | — | — | |
| 5 | Derivative | Emp. Stock Option (right to buy) | 2024-02-21 | A | A | 35,365 | $0.00 | 35,365 | D | $180.87 · 2025-02-21 to 2034-02-20 | 35,365 Common Stock | (F2) These derivative securities vest in four equal annual installments, the first vesting being on the date exercisable shown. All expire on the expiration date shown above. |
| 6 | Derivative | Rst. Stock Unit | 2024-02-21 | M | D | 2,269 | $0.00 | 6,808 | D | $0.00 · — to — | 2,269 Common Stock | (F3) These units were payable in cash or the company's common stock upon the lapse of the restrictions on the transaction date shown. |
| 7 | Derivative | Rst. Stock Unit | 2024-02-21 | A | A | 7,073 | $0.00 | 7,073 | D | $0.00 · — to — | 7,073 Common Stock | (F1) Upon lapse of the restrictions, these units are payable in cash or the company's common stock. The restrictions lapse for 1,768 of these units on February 21, 2025, 1,768 of these units on February 21, 2026, 1,768 of these units on February 21, 2027, and 1,769 of these units on February 21, 2028. |
| 8 | Derivative | Rst. Stock Unit | 2024-02-21 | M | D | 1,877 | $0.00 | 3,757 | D | $0.00 · — to — | 1,877 Common Stock | (F3) These units were payable in cash or the company's common stock upon the lapse of the restrictions on the transaction date shown. |